IOL CHEMICALS & PHARM. | ANG LIFESCIENCES INDIA | IOL CHEMICALS & PHARM./ ANG LIFESCIENCES INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.3 | -6.6 | - | View Chart |
P/BV | x | 1.5 | 0.8 | 177.7% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. ANG LIFESCIENCES INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ANG LIFESCIENCES INDIA Mar-23 |
IOL CHEMICALS & PHARM./ ANG LIFESCIENCES INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 276 | 194.5% | |
Low | Rs | 272 | 72 | 378.1% | |
Sales per share (Unadj.) | Rs | 377.6 | 168.4 | 224.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | -0.2 | -11,813.6% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 7.0 | 453.4% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 66.0 | 389.0% | |
Shares outstanding (eoy) | m | 58.71 | 13.06 | 449.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.0 | 103.6% | |
Avg P/E ratio | x | 17.1 | -867.2 | -2.0% | |
P/CF ratio (eoy) | x | 12.8 | 25.0 | 51.3% | |
Price / Book Value ratio | x | 1.6 | 2.6 | 59.8% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 2,272 | 1,045.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 240 | 701.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 2,199 | 1,008.3% | |
Other income | Rs m | 256 | 97 | 263.4% | |
Total revenues | Rs m | 22,427 | 2,296 | 976.7% | |
Gross profit | Rs m | 2,257 | 147 | 1,531.4% | |
Depreciation | Rs m | 462 | 94 | 493.5% | |
Interest | Rs m | 165 | 125 | 132.0% | |
Profit before tax | Rs m | 1,887 | 26 | 7,186.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 29 | 1,714.9% | |
Profit after tax | Rs m | 1,391 | -3 | -53,106.9% | |
Gross profit margin | % | 10.2 | 6.7 | 151.9% | |
Effective tax rate | % | 26.2 | 110.0 | 23.9% | |
Net profit margin | % | 6.3 | -0.1 | -5,265.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,852 | 522.0% | |
Current liabilities | Rs m | 5,025 | 1,623 | 309.7% | |
Net working cap to sales | % | 20.9 | 10.4 | 200.9% | |
Current ratio | x | 1.9 | 1.1 | 168.6% | |
Inventory Days | Days | 43 | 1 | 4,812.5% | |
Debtors Days | Days | 8 | 1,380 | 0.6% | |
Net fixed assets | Rs m | 11,017 | 887 | 1,242.3% | |
Share capital | Rs m | 587 | 131 | 449.6% | |
"Free" reserves | Rs m | 14,490 | 732 | 1,980.6% | |
Net worth | Rs m | 15,077 | 862 | 1,748.7% | |
Long term debt | Rs m | 0 | 205 | 0.0% | |
Total assets | Rs m | 20,684 | 2,756 | 750.6% | |
Interest coverage | x | 12.5 | 1.2 | 1,029.0% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.8 | 134.3% | |
Return on assets | % | 7.5 | 4.4 | 169.7% | |
Return on equity | % | 9.2 | -0.3 | -3,035.7% | |
Return on capital | % | 13.6 | 14.2 | 96.1% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 33 | 17,877.9% | |
Fx outflow | Rs m | 6,052 | 2 | 371,276.1% | |
Net fx | Rs m | -122 | 32 | -385.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 264 | 463.5% | |
From Investments | Rs m | -1,200 | -93 | 1,286.9% | |
From Financial Activity | Rs m | -41 | -171 | 24.1% | |
Net Cashflow | Rs m | -18 | 0 | 8,363.6% |
Indian Promoters | % | 48.2 | 70.6 | 68.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 29.4 | 176.2% | |
Shareholders | 130,003 | 7,055 | 1,842.7% | ||
Pledged promoter(s) holding | % | 0.0 | 44.9 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ANG LIFESCIENCES INDIA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.49% | -1.27% | -0.37% |
1-Month | -3.84% | 1.95% | 2.23% |
1-Year | -3.42% | -33.39% | 49.93% |
3-Year CAGR | -11.80% | 7.73% | 14.24% |
5-Year CAGR | 15.52% | 18.16% | 19.21% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ANG LIFESCIENCES INDIA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ANG LIFESCIENCES INDIA the stake stands at 70.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ANG LIFESCIENCES INDIA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ANG LIFESCIENCES INDIA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ANG LIFESCIENCES INDIA.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.